MYD88 and breast cancer: Furthermore, a review by Van der Merwe and colleagues [187] from South Africa that elucidated the possible mechanisms by which F. nucleatum might promote BC progression, also speculated that this particular bacterium may promote BC progression by activating the TLR4/MyD88 pathway through its immunomodulatory effects, as indicated in the literature for colorectal cancer.